Huntington's disease onset is determined by length of uninterrupted CAG, not encoded polyglutamine, and is modified by DNA maintenance mechanisms

J.-M. Lee, K. Correia, J. Loupe, K.-H. Kim,D. Barker,E. P. Hong,M. J. Chao,J. D. Long, D. Lucente, J.-P. Vonsattel,R. Mouro Pinto, K. Abu Elneel, E. M. Ramos, J. S. Mysore,T. Gillis,V. C. Wheeler,M. E. MacDonald,J. F. Gusella,T. Massey,B. McAllister, C. Medway, T. C. Stone,L. Hall,L. Jones,P. Holmans,S. Kwak, A. Ehrhardt,C. Sampaio,M. Ciosi, A. Maxwell, A. Chatzi,D. G. Monckton,M. Orth,G. B. Landwehrmeyer,J. S. Paulsen,E. R. Dorsey,I. Shoulson,R. H. Myers

bioRxiv(2019)

引用 3|浏览41
暂无评分
摘要
The effects of variable, glutamine-encoding, CAA interruptions indicate that a property of the uninterrupted HTT CAG repeat sequence, distinct from huntingtin9s segment, dictates the rate at which HD develops. The timing of onset shows no significant association with HTT cis-eQTLs but is influenced, sometimes in a sex-specific manner, by polymorphic variation at multiple DNA maintenance genes, suggesting that the special onset-determining property of the uninterrupted CAG repeat is a propensity for length instability that leads to its somatic expansion. Additional naturally-occurring genetic modifier loci, defined by GWAS, may influence HD pathogenesis through other mechanisms. These findings have profound implications for the pathogenesis of HD and other repeat diseases and question a fundamental premise of the polyglutamine disorders.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要